Consequently, the significant reduction in the expression of IGFBP-3 and IL-6, as a result of the inhibitory effects of these metabolites, leads to the emergence of abnormal blood glucose levels and the accompanying vasculopathy during the occurrence of diabetes in this study. The gene discussed is IL6; the disease is vascular disorder.